Abeona Therapeutics
(ABEO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,874 | -10,202 | -8,187 | -4,856 | -1,700 |
| Depreciation Amortization | 7,058 | 4,422 | 2,742 | 1,063 | 1,574 |
| Accounts receivable | 4,129 | 14 | N/A | N/A | 622 |
| Other Working Capital | 2,976 | 241 | -280 | 178 | 2,980 |
| Other Operating Activity | -3,247 | 1,333 | 2,407 | 2,268 | -10,777 |
| Operating Cash Flow | $-1,958 | $-4,192 | $-3,318 | $-1,347 | $-7,301 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,070 | -98 | -63 | -34 | 361 |
| PPE Investments | -3 | -3 | -3 | N/A | 307 |
| Net Acquisitions | 550 | N/A | N/A | N/A | 8,365 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 684 |
| Investing Cash Flow | $-2,523 | $-101 | $-66 | $-34 | $9,717 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,432 | 4,532 | 4,532 | 4,532 | 2,633 |
| Debt Repayment | -106 | -106 | -68 | -37 | -7,055 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 577 |
| Financing Cash Flow | $5,326 | $4,426 | $4,464 | $4,495 | $-3,845 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 3 |
| Beginning Cash Position | 349 | 349 | 349 | 349 | 1,775 |
| End Cash Position | 1,194 | 482 | 1,429 | 3,463 | 349 |
| Net Cash Flow | $845 | $133 | $1,080 | $3,114 | $-1,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,958 | -4,192 | -3,318 | -1,347 | -7,301 |
| Capital Expenditure | -3 | -3 | -3 | N/A | -28 |
| Free Cash Flow | -1,961 | -4,195 | -3,321 | -1,347 | -7,329 |